Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (211-220 of 350) with videos related to

Pageof 35
Sort By:
Molecular Cancer Research : MCR|July 15, 2018
Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 MutationsAnthony C Wang, David T W Jones, Isaac Joshua Abecassis, et al.
Oncotarget|May 7, 2015
Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patientsAndreas Mock, Rolf Warta, Christoph Geisenberger, et al.
Neurosurgery|June 23, 2026
Comparative Analysis of the Prognostic Value of Simpson Grade Versus MRI-Based Extent of Resection Paradigms Across Meningioma Histomolecular SubgroupsNadeem N Al-Adli, Felix Ehret, Minh P Nguyen, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Neuro-Oncology|November 23, 2017
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyElke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, et al.
The American Journal of Surgical Pathology|January 12, 2018
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC SubgroupPascal D Johann, Susanne Bens, Florian Oyen, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Neuro-Oncology Advances|July 3, 2024
Imaging meningioma biology: Machine learning predicts integrated risk score in WHO grade 2/3 meningiomaOlivia Kertels, Claire Delbridge, Felix Sahm, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classificationCynthia Hawkins, Kenneth Aldape, David Capper, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registryJonas Ecker, Florian Selt, Dominik Sturm, et al.
Pageof 35

Showing results (211-220 of 350) with videos related to

Sort By:
Pageof 35
Molecular Cancer Research : MCR|July 15, 2018
Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 MutationsAnthony C Wang, David T W Jones, Isaac Joshua Abecassis, et al.
Oncotarget|May 7, 2015
Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patientsAndreas Mock, Rolf Warta, Christoph Geisenberger, et al.
Neurosurgery|June 23, 2026
Comparative Analysis of the Prognostic Value of Simpson Grade Versus MRI-Based Extent of Resection Paradigms Across Meningioma Histomolecular SubgroupsNadeem N Al-Adli, Felix Ehret, Minh P Nguyen, et al.
Neuro-Oncology|January 12, 2023
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selectionDavid Capper, Guido Reifenberger, Pim J French, et al.
Neuro-Oncology|November 23, 2017
Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation-the NCT Neuro Master Match (N2M2) pilot studyElke Pfaff, Tobias Kessler, Gnana Prakash Balasubramanian, et al.
The American Journal of Surgical Pathology|January 12, 2018
Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC SubgroupPascal D Johann, Susanne Bens, Florian Oyen, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Neuro-Oncology Advances|July 3, 2024
Imaging meningioma biology: Machine learning predicts integrated risk score in WHO grade 2/3 meningiomaOlivia Kertels, Claire Delbridge, Felix Sahm, et al.
Brain Pathology (Zurich, Switzerland)|May 27, 2025
cIMPACT-NOW update 10: Recommendations for defining new types for central nervous system tumor classificationCynthia Hawkins, Kenneth Aldape, David Capper, et al.
European Journal of Cancer (Oxford, England : 1990)|December 21, 2022
Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registryJonas Ecker, Florian Selt, Dominik Sturm, et al.
Pageof 35